Skip to content

C. Ryan Miller Lab

Heersink School of Medicine

  • Home
  • Research
    • Dynamic profiling of the glioma kinome
    • Cellular and epigenetic biology of glioma stem cells
  • People
  • Lab Publications
    • CRM Publications
  • News
  • Lab Shenanigans
  • Contact

Miller awarded $3.09 million R01 to study drug targets for glioblastoma

Posted on March 7, 2022March 7, 2022Author rmiller

See UAB News for details.

Post navigation

Previous Previous post: Julia Ziebro advances to candidacy
Next Next post: Julia Ziebro Receives NextGen Predoctoral Scholar Award

Search This Site

Recent News

  • Julia Ziebro Receives NextGen Predoctoral Scholar Award
  • Miller awarded $3.09 million R01 to study drug targets for glioblastoma
  • Julia Ziebro advances to candidacy
  • Julia Ziebro named AMC21 Scholar
  • Miller Lab Alum Publishes Co-First Author Paper

Accessibility Toolbar

Theme: Maisha Lite
UAB the University of Alabama at Birmingham home
  • Login
  • |
  • Privacy
  • |
  • Terms of Use
  • |
  • © 2026 The University of Alabama at Birmingham
UAB is an Equal Employment/Equal Educational Opportunity Institution dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, sex (including pregnancy), genetic information, age, disability, religion, and veteran’s status. As required by Title IX, UAB prohibits sex discrimination in any education program or activity that it operates. Individuals may report concerns or questions to UAB’s Assistant Vice President and Senior Title IX Coordinator. The Title IX notice of nondiscrimination is located at uab.edu/titleix.